miR-140-3p enhances the sensitivity of LUAD cells to antitumor agents by targeting the ADAM10/Notch pathway.

Meng, Hao; Li, Bo; Xu, Wei; Ding, Renquan; Xu, Shiguang; Wu, Qiong; Zhang, Yingshi

Meng, Hao; Li, Bo; Xu, Wei; Ding, Renquan; Xu, Shiguang; Wu, Qiong; Zhang, Yingshi.

Afiliação

Meng H; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Li B; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Xu W; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Ding R; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Xu S; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Wu Q; Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang City 110011, Liaoning Province, China.
Zhang Y; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang City 110011, Liaoning Province, China.

J Cancer ; 13(15): 3660-3673, 2022.

Article em En | MEDLINE | ID: mdl-36606198

Palavras-chave

A disintegrin and metalloproteinase domain 10; Notch pathway; chemotherapeutic agents; miR-140-3p; molecular targeted agents

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google